PCM
ATRC icon

Peregrine Capital Management’s AtriCure ATRC Stock Holding History

Peregrine Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-161,646
Closed -$6.7M – 321
2023
Q1 		$6.7M Buy
161,646
+4,783
+3% +$198K 0.19% 223
2022
Q4 		$6.96M Sell
156,863
-50,361
-24% -$2.1M 0.22% 211
2022
Q3 		$8.1M Sell
207,224
-83,591
-29% -$3.82M 0.26% 181
2022
Q2 		$11.9M Buy
290,815
+49,202
+20% +$2.33M 0.36% 87
2022
Q1 		$15.9M Sell
241,613
-20,685
-8% -$1.34M 0.38% 69
2021
Q4 		$18.2M Buy
262,298
+20,129
+8% +$1.46M 0.37% 65
2021
Q3 		$16.8M Sell
242,169
-54,228
-18% -$4.17M 0.35% 73
2021
Q2 		$23.5M Sell
296,397
-32,808
-10% -$2.39M 0.42% 52
2021
Q1 		$21.6M Sell
329,205
-45,905
-12% -$2.83M 0.4% 73
2020
Q4 		$20.9M Buy
375,110
+53,658
+17% +$2.32M 0.4% 77
2020
Q3 		$12.8M Buy
321,452
+1,367
+0.4% +$58K 0.34% 110
2020
Q2 		$14.4M Sell
320,085
-47,151
-13% -$2.05M 0.41% 99
2020
Q1 		$12.3M Sell
367,236
-396,735
-52% -$14.3M 0.44% 91
2019
Q4 		$24.8M Sell
763,971
-44,575
-6% -$1.27M 0.63% 44
2019
Q3 		$20.2M Buy
808,546
+132,778
+20% +$3.79M 0.55% 67
2019
Q2 		$20.2M Sell
675,768
-53,656
-7% -$1.57M 0.5% 77
2019
Q1 		$19.5M Buy
729,424
+52,022
+8% +$1.58M 0.49% 79
2018
Q4 		$20.7M Sell
677,402
-9,155
-1% -$285K 0.58% 52
2018
Q3 		$24.1M Sell
686,557
-209,018
-23% -$6.62M 0.57% 68
2018
Q2 		$24.2M Sell
895,575
-170,833
-16% -$4.01M 0.61% 56
2018
Q1 		$21.9M Sell
1,066,408
-67,998
-6% -$1.23M 0.54% 63
2017
Q4 		$20.7M Buy
1,134,406
+209,666
+23% +$4.15M 0.49% 69
2017
Q3 		$20.7M Buy
924,740
+31,526
+4% +$713K 0.5% 70
2017
Q2 		$21.7M Sell
893,214
-101,377
-10% -$2.16M 0.54% 63
2017
Q1 		$18.8M Buy
994,591
+92,071
+10% +$1.61M 0.48% 76
2016
Q4 		$17.7M Sell
902,520
-122,347
-12% -$2.22M 0.46% 75
2016
Q3 		$16.2M Buy
+1,024,867
New +$15.8M 0.42% 90

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Peregrine Capital Management's ATRC Position: Q2 2023 in Review

Peregrine Capital Management sold out of AtriCure (ATRC) in Q2 2023, closing a stake of 161,646 shares — an estimated $6.7M sold.

Peregrine Capital Management first reported a position in ATRC in Q3 2016 and held it in 27 quarters. The position peaked at $24.8M in Q4 2019. 223 funds tracked by Wall St. Rank hold ATRC as of Q2 2023.

  • Peregrine Capital Management reported no remaining AtriCure position as of Q2 2023 after selling out during the quarter.
  • Peregrine Capital Management sold 161,646 AtriCure shares in Q2 2023, an estimated $6.7M.
  • Peregrine Capital Management first reported a position in AtriCure in Q3 2016 and held it in 27 quarters.
  • Peregrine Capital Management's AtriCure position peaked at $24.8M in Q4 2019.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q2 2023.

Based on Peregrine Capital Management's 13F filing for Q2 2023, filed 26 Jul 2023.